Elevated plus maze

Last updated
Schematic drawing of an elevated plus maze. ElevatedPlusMaze.svg
Schematic drawing of an elevated plus maze.

The elevated plus maze (EPM) is a test measuring anxiety in laboratory animals that usually uses rodents as a screening test for putative anxiolytic or anxiogenic compounds and as a general research tool in neurobiological anxiety research such as PTSD and TBI. [1] The model is based on the test animal's aversion to open spaces and tendency to be thigmotaxic. In the EPM, this anxiety is expressed by the animal spending more time in the enclosed arms. The validity of the model has been criticized as non-classical clinical anxiolytics produce mixed results in the EPM test. Despite this, the model is still commonly used for screening putative anxiolytics and for general research into the brain mechanisms of anxiety.

Contents

Method

An elevated plus maze (for mice) +maze.jpg
An elevated plus maze (for mice)

The test uses an elevated, plus-shaped (+) apparatus with two open and two enclosed arms. The behavioral model is based on the general aversion of rodents to open spaces. This aversion leads to thigmotaxis: a preference for remaining in enclosed spaces or close to the edges of a bounded space. In the EPM, this translates into the animals limiting their movement to the enclosed arms. [2] [3] [4] [5]

Anxiety reduction is indicated in the plus-maze by an increase in the proportion of time spent in the open arms (time in open arms/total time in open or closed arms) and an increase in the proportion of entries into the open arms (entries into open arms/total entries into open or closed arms). The total number of arm entries and number of closed-arm entries are sometimes used as measures of general activity. [6] The relationship between the EPM and other tests of exploratory activity (open-field and emergence) have been analyzed in two mouse strains. [7]

Criticism

While EPM is the most commonly employed animal behavioral model of anxiety, there are several issues concerning the validity of the model. Classical clinical anxiolytics, such as benzodiazepines (e.g., Valium), do reduce measures of anxiety in EPM. However, more novel compounds, such as 5-HT1A agonists (e.g., Buspar) give mixed results. Selective serotonin reuptake inhibitors and tricyclic antidepressants, which are commonly employed in clinical settings to treat anxiety disorders, also do not lead to a stable anxiolytic effect on EPM. [5] This raises the possibility that EPM is a suitable model for testing GABA-related compounds, such as benzodiazepines or direct GABAA agonists, but not for other drugs. Despite this, the model is commonly employed for screening putative anxiolytics and for general research into the brain mechanisms of anxiety, [8] likely due to the ease of employment and the vast number of studies already in the literature.

Variations

Elevated zero maze

Elevated zero maze (mouse can be seen in the top right) Elevated Zero Maze.jpg
Elevated zero maze (mouse can be seen in the top right)

The elevated zero maze (EZM) is an elevated circular runway with alternating open light areas and enclosed dark areas. [9] [10] The continuous nature of this apparatus eliminates the problem of the EPM in how to account for the animal's presence in the center area of the EPM. In the EPM test, animals may spend up to 30% of their time in the ambiguous central start area or return to it often, making it difficult to evaluate the biological significance of anxiety related behaviour. Animal will return to the central area because they are habituated to that area and associate it with being "safe". [11]

Untreated rodents show a higher exploration of open areas in the EZM than in the EPM. This could indicate the EPM inhibits exploration, but the fact that rodents spent time in the central zone of the EPM needs to be taken into account. The EZM is more sensitive to changes than the EPM due to the baseline level in the EZM being lower than the EPM. [9]

Elevated T maze

The elevated T maze (ETM) has three arms in the shape of the letter "T". One arm is closed and perpendicular to the other two arms which are open. This test is designed to observe anxiety effects and how it affects learning. The rodent is placed on the enclosed arm and allowed to explore. The trial ends when the rodents sets all four paws in one of the open arms. Rodents are allowed multiple trials until they learn to stay in one of the open arms for 300 seconds. This is a measurement of inhibitory avoidance. Depending on what the rodents were treated with during the training sessions, they would learn at different rates giving information on how the brain stores memories. [12] This test can be used to assess long term memory. When a rodent has been sufficiently trained, researchers will test the rodent again after a week to observe if the rodent still remembers to stay in the enclosed arm.

Plus-maze discriminative avoidance test

Schematic representation of the apparatus used for the plus-maze discriminative avoidance test. Plus-Maze Discriminative Avoidance Task Apparatus.tiff
Schematic representation of the apparatus used for the plus-maze discriminative avoidance test.

Like the standard EPM, the apparatus used in the plus-maze discriminative avoidance test (PMDAT) has four arms. This test has been used to investigate interactions between aversive memory and anxiety responses in rodents. The apparatus has two open arms opposite to two enclosed arms. In this test, one of the enclosed arms is paired with aversive stimuli (e.g. bright light, loud white noise). During training, animals are placed in the apparatus facing the intercept between the open arms. Each time the animal enters the aversive enclosed arm, the aversive stimulus is presented until the animal leaves the arm. Upon a second exposure to the maze (e.g. 24 h later) the aversive stimuli is no longer presented. Retention of the aversive memory is assessed based on the relative time spent in the non-aversive arm compared to the previously aversive arm and anxiety behavior is calculated based on the time spent in the open arms during the training session. [13]

Multivariate Concentric Square Field test (MCSF-test)

The MCSF-test is a behaviour model used to study risk assessment, risk taking, anxiety and security seeking behaviour. It has a completely different design compared to the t-maze, but instead of using a battery of different behaviour models this test can be used to measure a variety of dependent and independent variables. In this context "multivariate" is defined as that the subject has a free choice of different environments contained in the same apparatus and session. [14]

The MCSF consists of different areas associated with risk-taking and shelter-seeking. The subject can therefore choose between locations with different qualities regarding open areas, illuminations, shelter and exploratory challenges. The arena consists of a dark room enclosed by walls and ceiling, dimly illuminated corridors, open area with moderate illumination, a hole-board area which requires a certain physical effort to reach and an elevated bridge with high illumination. [14]

Elevated plus maze for humans using virtual reality

Using a combination of virtual reality and real-world elements, the EPM has been transferred to usage with humans. [15] Participants who partook in the study were placed on a 3.5 by 3.5 meters wide and 0.3m high wooden cross while wearing a virtual reality headset. In the virtual environment, the real cross was matched in exact dimension and orientation. Open arms were above a 50-meter drop over open water, while the closed arms were surrounded by a stable and firm surface around the platform. [15] Similar to the observed rodent behavior on an EPM, participants reported higher anxiety on open arms while also avoiding those more. Participants with high anxiety also exhibited higher avoidance of open arms. [15]

See also

Related Research Articles

<span class="mw-page-title-main">5-HT receptor</span> Class of transmembrane proteins

5-HT receptors, 5-hydroxytryptamine receptors, or serotonin receptors, are a group of G protein-coupled receptor and ligand-gated ion channels found in the central and peripheral nervous systems. They mediate both excitatory and inhibitory neurotransmission. The serotonin receptors are activated by the neurotransmitter serotonin, which acts as their natural ligand.

<span class="mw-page-title-main">Morris water navigation task</span> Task used in experiments to measure spatial learning and memory

The Morris water navigation task, also known as the Morris water maze, is a behavioral procedure mostly used with rodents. It is widely used in behavioral neuroscience to study spatial learning and memory. It enables learning, memory, and spatial working to be studied with great accuracy, and can also be used to assess damage to particular cortical regions of the brain. It is used by neuroscientists to measure the effect of neurocognitive disorders on spatial learning and possible neural treatments, to test the effect of lesions to the brain in areas concerned with memory, and to study how age influences cognitive function and spatial learning. The task is also used as a tool to study drug-abuse, neural systems, neurotransmitters, and brain development.

<span class="mw-page-title-main">AP-7 (drug)</span> Chemical compound

AP-7 is a selective NMDA receptor (NMDAR) antagonist that competitively inhibits the glutamate binding site and thus activation of NMDAR. It has anticonvulsant effects.

<span class="mw-page-title-main">Barnes maze</span>

The Barnes maze is a tool used in psychological laboratory experiments to measure spatial learning and memory. The test was first developed by Dr. Carol Barnes in 1979. The test subjects are usually rodents such as mice or lab rats, which either serve as a control or may have some genetic variable or deficiency present in them which will cause them to react to the maze differently. The basic function of Barnes maze is to measure the ability of a mouse to learn and remember the location of a target zone using a configuration of distal visual cues located around the testing area. This noninvasive task is useful for evaluating novel chemical entities for their effects on cognition as well as identifying cognitive deficits in transgenic strains of rodents that model for disease such as Alzheimer's disease. It is also used by neuroscientists to determine whether there is a causative effect after mild traumatic brain injury on learning deficits and spatial memory retention (probe) at acute and chronic time points. This task is dependent on the intrinsic inclination of the subjects to escape from an aversive environment and on hippocampal-dependent spatial reference memory.

An anxiogenic or panicogenic substance is one that causes anxiety. This effect is in contrast to anxiolytic agents, which inhibits anxiety. Together these categories of psychoactive compounds may be referred to as anxiotropic compounds.

<span class="mw-page-title-main">Eglumetad</span> Chemical compound

Eglumetad is a research drug developed by Eli Lilly and Company, which is being investigated for its potential in the treatment of anxiety and drug addiction. It is a glutamate derived compound and its mode of action implies a novel mechanism.

<span class="mw-page-title-main">CGS-9896</span> Anxiolytic drug used in scientific research

CGS-9896 is an anxiolytic drug used in scientific research. It has similar effects to benzodiazepine drugs but is structurally distinct and so is classed as a nonbenzodiazepine anxiolytic.

<span class="mw-page-title-main">Conditioned place preference</span> Pavlovian conditioning

Conditioned place preference (CPP) is a form of Pavlovian conditioning used to measure the motivational effects of objects or experiences. This motivation comes from the pleasurable aspect of the experience, so that the brain can be reminded of the context that surrounded the "encounter". By measuring the amount of time an animal spends in an area that has been associated with a stimulus, researchers can infer the animal's liking for the stimulus. This paradigm can also be used to measure conditioned place aversion with an identical procedure involving aversive stimuli instead. Both procedures usually involve mice or rats as subjects. This procedure can be used to measure extinction and reinstatement of the conditioned stimulus. Certain drugs are used in this paradigm to measure their reinforcing properties. Two different methods are used to choose the compartments to be conditioned, and these are biased vs. unbiased. The biased method allows the animal to explore the apparatus, and the compartment they least prefer is the one that the drug is administered in and the one they most prefer is the one where the vehicle is injected. This method allows the animal to choose the compartment they get the drug and vehicle. In comparison, the unbiased method does not allow the animal to choose what compartment they get the drug and vehicle in. Instead, the researcher chooses the compartments.

<span class="mw-page-title-main">Rotarod performance test</span>

The rotarod performance test is a performance test based on a rotating rod with forced motor activity being applied, usually by a rodent. The test measures parameters such as riding time (seconds) or endurance. Some of the functions of the test include evaluating balance, grip strength and motor coordination of the subjects; especially in testing the effect of experimental drugs or after traumatic brain injury.

<span class="mw-page-title-main">Osemozotan</span> Pharmaceutical drug

Osemozotan (MKC-242) is a selective 5-HT1A receptor agonist with some functional selectivity, acting as a full agonist at presynaptic and a partial agonist at postsynaptic 5-HT1A receptors. 5-HT1A receptor stimulation influences the release of various neurotransmitters including serotonin, dopamine, norepinephrine, and acetylcholine. 5-HT1A receptors are inhibitory G protein-coupled receptor. Osemozotan has antidepressant, anxiolytic, antiobsessional, serenic, and analgesic effects in animal studies, and is used to investigate the role of 5-HT1A receptors in modulating the release of dopamine and serotonin in the brain, and their involvement in addiction to abused stimulants such as cocaine and methamphetamine.

<span class="mw-page-title-main">Jacqueline Crawley</span> American behavioral neuroscientist

Jacqueline N. Crawley is an American behavioral neuroscientist and an expert on rodent behavioral analysis. Since July 2012, she is the Robert E. Chason Chair in Translational Research in the MIND Institute and professor of psychiatry and behavioral sciences at the University of California, Davis School of Medicine in Sacramento. Previously, from 1983–2012, she was chief of the Laboratory of Behavioral Neuroscience in the intramural program of the National Institute of Mental Health. Her translational research program focuses on testing hypotheses about the genetic causes of autism spectrum disorders and discovering treatments for the diagnostic symptoms of autism, using mouse models. She has published more than 275 peer-reviewed articles in scientific journals and 110 review articles and book chapters. According to Scopus, her works have been cited over 36,000 times, giving her an h-index of 99. She has co-edited 4 books and is the author of What's Wrong With my Mouse? Behavioral Phenotyping of Transgenic and Knockout Mice, which was very well received.

The hot plate test is a test of the pain response in animals, similar to the tail flick test. Both hot plate and tail-flick methods are used generally for centrally acting analgesic, while peripherally acting drugs are ineffective in these tests but sensitive to acetic acid-induced writhing test.

Animal models of depression are research tools used to investigate depression and action of antidepressants as a simulation to investigate the symptomatology and pathophysiology of depressive illness or used to screen novel antidepressants. These models provide insights into molecular, genetic, and epigenetic factors associated with depression. Criteria for valid animal models include face, construct, and predictive validity. Endophenotypes, such as anhedonia, behavioral despair, changes in appetite, neuroanatomical alterations, neuroendocrine disturbances, alterations in sleep architecture, and anxiety-related behaviors, are evaluated in these models. Antidepressant screening tests are employed to assess the effects of genetic, pharmacological, or environmental manipulations. Stress models, including learned helplessness, chronic mild stress, and social defeat stress, simulate the impact of stressors on depression. Early life stress models, psychostimulant withdrawal models, olfactory bulbectomy, and genetically engineered mice contribute to a comprehensive understanding of depression's etiology and potential therapeutic interventions.

Developed by Calvin S. Hall, the open field test is an experimental test used to assay general locomotor activity levels, anxiety, and willingness to explore in animals in scientific research. However, the extent to which behavior in the open field measures anxiety is controversial. The open field test can be used to assess memory by evaluating the ability of the animal to recognize a stimuli or object. Another animal test that is used to assess memory using that same concept is the novel object recognition test.

The hole-board test (HBT) is an experimental method used in scientific research to measure anxiety, stress, neophilia and emotionality in animals. Because of its ability to measure multiple behaviors it is a popular test in behavioral pharmacology, but the results are controversial.

<span class="mw-page-title-main">T-maze</span> Forked passage used in animal cognition tests

In behavioral science, a T-maze is a simple forked passage used in animal cognition experiments. It is shaped like the letter T, providing the subject, typically a rodent, with a straightforward choice. T-mazes are used to study how the rodents function with memory and spatial learning through applying various stimuli. Starting in the early 20th century, rodents were used in experiments such as the T-maze. These concepts of T-mazes are used to assess rodent behavior. The different tasks, such as left-right discrimination and forced alternation, are mainly used with rodents to test reference and working memory.

An anxiotropic agent is one that modifies anxiety, a human emotion that has homologous processes in animals. In psychopharmacology anxiotropic agents consist of two categories of psychoactive drugs: anxiolytics that reduce anxiety and may be used therapeutically, and anxiogenic compounds that increase anxiety.

<span class="mw-page-title-main">Marble burying</span> Animal model used in scientific research

Marble burying is an animal model used in scientific research to depict anxiety or obsessive–compulsive disorder (OCD) behavior. It is based on the observation that rats and mice will bury either harmful or harmless objects in their bedding. While widely used there is significant controversy over the interpretation of its results.

<span class="mw-page-title-main">Light-dark box test</span>

The light-dark box test (LDB) is a popular animal model used in pharmacology to assay unconditioned anxiety responses in rodents. The extent to which behavior in the LDB measures anxiety is controversial.

<span class="mw-page-title-main">GML-1</span> Chemical compound

GML-1 is a TSPO ligand with anxiolytic activity. Its binding affinity to TSPO is comparable with PK11195. GML-1 is selective for TSPO versus the central benzodiazepine receptor. The compound GML-1 was the most active of a series of 1-arylpyrrolo[1,2-a]pyrazine-3-carboxamides, and its anxiolytic effects were examined using the open field test (OFT) and the elevated plus maze (EPM) test. The EPM test is a general anxiety test measuring the time spent by animals in the open or the enclosed arms. When compound was administered to CD-1 mice at the dose of 1.0 mg/kg, it significantly increased the percentage of open arm entries and the time spent in the open arms. GML-1 is a potential antianxiety agent.

References

  1. ↑ Ojo, J; Mouzon, B (May 2016). "Chronic Repetitive Mild Traumatic Brain Injury Results in Reduced Cerebral Blood Flow, Axonal Injury, Gliosis, and Increased T-Tau and Tau Oligomers". J Neuropathol Exp Neurol. 75 (7): 636–55. doi:10.1093/jnen/nlw035. PMC   4913432 . PMID   27251042.
  2. ↑ Pellow, S., Chopin, P., File, S.E. and Briley, M. (1985). "Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat". J. Neurosci. Methods. 14 (3): 149–67. doi:10.1016/0165-0270(85)90031-7. PMID   2864480. S2CID   24168485.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  3. ↑ Treit, D., Menard, J. and Royan, C. (1993). "Anxiogenic stimuli in the elevated plus-maze". Pharmacol. Biochem. Behav. 44 (2): 463–469. doi:10.1016/0091-3057(93)90492-c. PMID   8446680. S2CID   35350195.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  4. ↑ Rodgers, R.J. (1997). "Animal models of anxiety: where next?". Behav. Pharmacol. 8 (6–7): 477–496. doi:10.1097/00008877-199711000-00003. PMID   9832964.
  5. 1 2 Carobrez, A.P.; Bertoglio, L.J. (2005). "Ethological and temporal analyses of anxiety-like behavior: the elevated plus-maze model 20 years on". Neurosci. Biobehav. Rev. 29 (8): 1193–1205. doi:10.1016/j.neubiorev.2005.04.017. PMID   16084592. S2CID   514205.
  6. ↑ Hogg S.A. (1996). "Review of the validity and variability of the elevated plus-maze as an animal model of anxiety". Pharmacol. Biochem. Behav. 54 (1): 21–30. doi:10.1016/0091-3057(95)02126-4. PMID   8728535. S2CID   7390888.
  7. ↑ Lalonde, R; Strazielle C (2008). "Relations between open-field, elevated plus-maze, and emergence tests as displayed by C57/BL6J and BALB/c mice". Journal of Neuroscience Methods. 171 (1): 48–52. doi:10.1016/j.jneumeth.2008.02.003. PMID   18358538. S2CID   27056010.
  8. ↑ Engin, E.; Treit, D. (2008). "The effects of intra-cerebral drug infusions on animals' unconditioned fear reactions: A systematic review". Prog. Neuropsychopharmacol. Biol. Psychiatry. 32 (6): 1399–1419. doi:10.1016/j.pnpbp.2008.03.020. PMID   18495312. S2CID   39534294.
  9. 1 2 Braun, Amanda A; Skelton, Matthew R; Vorhees, Charles V; Williams, Michael Y (2011). "Comparison of the elevated plus and elevated zero mazes in treated and untreated male Sprague-Dawley rats: Effects of anxiolytic and anxiogenic agents". Pharmacol Biochem Behav. 97 (3): 406–415. doi:10.1016/j.pbb.2010.09.013. PMC   3006066 . PMID   20869983.
  10. ↑ Campos, Alline C; Fogaca, Manoela V; Aguiar, Daniele C; Guimaraes, Francisco S (2013). "Animal models of anxiety disorders and stress". Revista Brasileira de Psiquiatria. 35: 101–111.
  11. ↑ Bailey, KR; Crawley, JN (2009). Methods of Behavior Analysis in Neuroscience (2nd ed.). Boca Raton (FL): CRC Press/Taylor & Francis. ISBN   978-1-4200-5234-3. PMID   21204329 . Retrieved 13 April 2016.
  12. ↑ Asth, Laila; Rachetti, Vanessa; Gavioli, Elaine C; Andre, Eunice; Lobao-Soares, Bruno (2012). "The elevated T-maze task as an animal model to simultaneously investigate the effects of drugs on long-term memory and anxiety in mice". Brain Research Bulletin. 87 (6): 526–533. doi: 10.1016/j.brainresbull.2012.02.008 . PMID   22394406. S2CID   15198930.
  13. ↑ Leão, Anderson; Medeiros, Andre; Apolinario, Genedy; Cabral, Alicia; Ribeiro, Alessandra; Barbosa, Flavio; Silva, Regina (2016). "Hippocampal-dependent memory in the plus-maze discriminative avoidance task: The role of spatial cues and CA1 activity". Behavioural Brain Research. 304: 24–33. doi:10.1016/j.bbr.2016.02.012. PMID   26876135. S2CID   23591620.
  14. 1 2 Meyerson, Bengt J.; Augustsson, Hanna; Berg, Marita; Roman, Erika (2006). "The Concentric Square Field: A multivariate test arena for analysis of explorative strategies". Behavioural Brain Research. 168 (1): 100–113. doi:10.1016/j.bbr.2005.10.020. PMID   16356558. S2CID   21991.
  15. 1 2 3 Biedermann, Sarah V.; Biedermann, Daniel G.; Wenzlaff, Frederike; Kurjak, Tim; Nouri, Sawis; Auer, Matthias K.; Wiedemann, Klaus; Briken, Peer; Fuss, Johannes (2017-12-21). "An elevated plus-maze in mixed reality for studying human anxiety-related behavior". BMC Biology. 15 (1): 125. doi: 10.1186/s12915-017-0463-6 . ISSN   1741-7007. PMC   5740602 . PMID   29268740.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.